Accelerating implementation of biomedical research advances: critical elements of a successful 10 year Cystic Fibrosis Foundation healthcare delivery improvement initiative (Q38194428)

From Wikidata

Jump to navigation Jump to search

scientific article published on April 2014

Language	Label	Description	Also known as
English	Accelerating implementation of biomedical research advances: critical elements of a successful 10 year Cystic Fibrosis Foundation healthcare delivery improvement initiative	scientific article published on April 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

1 reference

Europe PubMed Central

Accelerating implementation of biomedical research advances: critical elements of a successful 10 year Cystic Fibrosis Foundation healthcare delivery improvement initiative (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

cystic fibrosis

0 references

author name string

Bruce C Marshall

1

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

Eugene C Nelson

2

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

publication date

1 April 2014

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

BMJ Quality & Safety

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

23 Suppl 1

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

i95-i103

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

CYSTIC FIBROSIS OF THE PANCREAS AND ITS RELATION TO CELIAC DISEASE

1 reference

https://api.crossref.org/works/10.1136%2FBMJQS-2013-002790

21 January 2018

Chloride impermeability in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1136%2FBMJQS-2013-002790

21 January 2018

Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA

1 reference

https://api.crossref.org/works/10.1136%2FBMJQS-2013-002790

21 January 2018

Generation of cAMP-Activated Chloride Currents by Expression of CFTR

1 reference

https://api.crossref.org/works/10.1136%2FBMJQS-2013-002790

21 January 2018

Moving forward: cystic fibrosis gene therapy

1 reference

https://api.crossref.org/works/10.1136%2FBMJQS-2013-002790

21 January 2018

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group

1 reference

https://api.crossref.org/works/10.1136%2FBMJQS-2013-002790

21 January 2018

Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1136%2FBMJQS-2013-002790

21 January 2018

A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1136%2FBMJQS-2013-002790

21 January 2018

Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1136%2FBMJQS-2013-002790

21 January 2018

Inhaled Aztreonam Lysine for Chronic Airway Pseudomonas aeruginosa in Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1136%2FBMJQS-2013-002790

21 January 2018

Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health

1 reference

https://api.crossref.org/works/10.1136%2FBMJQS-2013-002790

21 January 2018

Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health.

1 reference

https://api.crossref.org/works/10.1136%2FBMJQS-2013-002790

21 January 2018

A CFTR potentiator in patients with cystic fibrosis and the G551D mutation

1 reference

https://api.crossref.org/works/10.1136%2FBMJQS-2013-002790

21 January 2018

Increased adherence to CFF practice guidelines for pulmonary medications correlates with improved FEV1.

1 reference

https://api.crossref.org/works/10.1136%2FBMJQS-2013-002790

21 January 2018

The Cystic Fibrosis Foundation Patient Registry as a tool for use in quality improvement

1 reference

https://api.crossref.org/works/10.1136%2FBMJQS-2013-002790

21 January 2018

Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review

1 reference

https://api.crossref.org/works/10.1136%2FBMJQS-2013-002790

21 January 2018

Specialist physician practices as patient-centered medical homes

1 reference

https://api.crossref.org/works/10.1136%2FBMJQS-2013-002790

21 January 2018

Rx for the 'blockbuster drug' of patient engagement.

1 reference

https://api.crossref.org/works/10.1136%2FBMJQS-2013-002790

21 January 2018

Development and validation of a cystic fibrosis patient and family member experience of care survey

1 reference

https://api.crossref.org/works/10.1136%2FBMJQS-2013-002790

21 January 2018

Accurate assessment of adherence: self-report and clinician report vs electronic monitoring of nebulizers.

1 reference

https://api.crossref.org/works/10.1136%2FBMJQS-2013-002790

21 January 2018

The randomized registry trial--the next disruptive technology in clinical research?

1 reference

https://api.crossref.org/works/10.1136%2FBMJQS-2013-002790

21 January 2018

Identifiers

10.1136/BMJQS-2013-002790

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

release_w3an5yubnfaqphaypedxa2ndta

1 reference

https://api.fatcat.wiki/v0/release/w3an5yubnfaqphaypedxa2ndta

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38194428&oldid=2104084462"